# Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19

arXiv: https://arxiv.org/abs/2004.07229 · HTML: https://mlsanity.com/paper/2004.07229/

## Key facts

- Cited by 39 papers in the map (data through 14 Oct 2026).
- First posted on arXiv 15 Apr 2020.

## Built on by (most cited first, 30 of 39)

- [Geometric Deep Learning: Grids, Groups, Graphs, Geodesics, and Gauges](https://mlsanity.com/paper/2104.13478/) (2021)
- [Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development](https://mlsanity.com/paper/2102.09548/) (2021)
- [Towards a Unified Framework for Fair and Stable Graph Representation Learning](https://mlsanity.com/paper/2102.13186/) (2021)
- [Evaluating Explainability for Graph Neural Networks](https://mlsanity.com/paper/2208.09339/) (2022)
- [Everything is Connected: Graph Neural Networks](https://mlsanity.com/paper/2301.08210/) (2023)
- [Graph Representation Learning in Biomedicine](https://mlsanity.com/paper/2104.04883/) (2021)
- [DrugOOD: Out-of-Distribution (OOD) Dataset Curator and Benchmark for AI-aided Drug Discovery -- A Focus on Affinity Prediction Problems with Noise Annotations](https://mlsanity.com/paper/2201.09637/) (2022)
- [GNNDelete: A General Strategy for Unlearning in Graph Neural Networks](https://mlsanity.com/paper/2302.13406/) (2023)
- [Automated Machine Learning on Graphs: A Survey](https://mlsanity.com/paper/2103.00742/) (2021)
- [Accelerating science with human-aware artificial intelligence](https://mlsanity.com/paper/2306.01495/) (2023)
- [Learning Invariant Molecular Representation in Latent Discrete Space](https://mlsanity.com/paper/2310.14170/) (2023)
- [Graph Learning under Distribution Shifts: A Comprehensive Survey on Domain Adaptation, Out-of-distribution, and Continual Learning](https://mlsanity.com/paper/2402.16374/) (2024)
- [Deep learning for drug repurposing: methods, databases, and applications](https://mlsanity.com/paper/2202.05145/) (2022)
- [Multi-task Joint Strategies of Self-supervised Representation Learning on Biomedical Networks for Drug Discovery](https://mlsanity.com/paper/2201.04437/) (2022)
- [Knowledge Graphs for the Life Sciences: Recent Developments, Challenges and Opportunities](https://mlsanity.com/paper/2309.17255/) (2023)
- [Automated Graph Machine Learning: Approaches, Libraries, Benchmarks and Directions](https://mlsanity.com/paper/2201.01288/) (2022)
- [A Distant Supervision Corpus for Extracting Biomedical Relationships Between Chemicals, Diseases and Genes](https://mlsanity.com/paper/2204.06584/) (2022)
- [Sampling Enclosing Subgraphs for Link Prediction](https://mlsanity.com/paper/2206.12004/) (2022)
- [Explainable Biomedical Recommendations via Reinforcement Learning Reasoning on Knowledge Graphs](https://mlsanity.com/paper/2111.10625/) (2021)
- [BioBLP: A Modular Framework for Learning on Multimodal Biomedical Knowledge Graphs](https://mlsanity.com/paper/2306.03606/) (2023)
- [KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description](https://mlsanity.com/paper/2212.01384/) (2022)
- [Synthetic Data from Diffusion Models Improve Drug Discovery Prediction](https://mlsanity.com/paper/2405.03799/) (2024)
- [Graph Neural Networks on Quantum Computers](https://mlsanity.com/paper/2405.17060/) (2024)
- [Accelerating science with human versus alien artificial intelligences](https://mlsanity.com/paper/2104.05188/) (2021)
- [The maximum capability of a topological feature in link prediction](https://mlsanity.com/paper/2206.15101/) (2022)
- [Stochastic Subgraph Neighborhood Pooling for Subgraph Classification](https://mlsanity.com/paper/2304.08556/) (2023)
- [Graph AI in Medicine](https://mlsanity.com/paper/2310.13767/) (2023)
- [Accelerating Complex Disease Treatment through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer](https://mlsanity.com/paper/2406.13106/) (2024)
- [Complementary artificial intelligence designed to augment human discovery](https://mlsanity.com/paper/2207.00902/) (2022)
- [Knowledge Graphs are not Created Equal: Exploring the Properties and Structure of Real KGs](https://mlsanity.com/paper/2311.06414/) (2023)

## Abstract (arXiv)

The current pandemic has highlighted the need for methodologies that can quickly and reliably prioritize clinically approved compounds for their potential effectiveness for SARS-CoV-2 infections. In the past decade, network medicine has developed and validated multiple predictive algorithms for drug repurposing, exploiting the sub-cellular network-based relationship between a drug's targets and disease genes. Here, we deployed algorithms relying on artificial intelligence, network diffusion, and network proximity, tasking each of them to rank 6,340 drugs for their expected efficacy against SARS-CoV-2. To test the predictions, we used as ground truth 918 drugs that had been experimentally screened in VeroE6 cells, and the list of drugs under clinical trial, that capture the medical community's assessment of drugs with potential COVID-19 efficacy. We find that while most algorithms offer predictive power for these ground truth data, no single method offers consistently reliable outcomes across all datasets and metrics. This prompted us to develop a multimodal approach that fuses the predictions of all algorithms, showing that a consensus among the different predictive methods consistently exceeds the performance of the best individual pipelines. We find that 76 of the 77 drugs that successfully reduced viral infection do not bind the proteins targeted by SARS-CoV-2, indicating that these drugs rely on network-based actions that cannot be identified using docking-based strategies. These advances offer a methodological pathway to identify repurposable drugs for future pathogens and neglected diseases underserved by the costs and extended timeline of de novo drug development.